Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute cardiometabolic risks of haloperidol in elderly orthopedic surgery patients
NL-OMON37239Withdrawn
- Sponsor
- Tergooi MC
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of haloperidol in delirium and agitation (2 arms), sponsored by Tergooi MC. Primary endpoints: Fasting serum glucose and QTc prolongation. Planned start Jan 2013; status: withdrawn.
02
Drugs
haloperidol
03
Conditions
deliriumagitation
Beyond the preview
Go deeper on NL-OMON37239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37239.